Biofrontera Stock Forecast - Simple Exponential Smoothing

BFRI Stock  USD 0.82  0.02  2.50%   
The Simple Exponential Smoothing forecasted value of Biofrontera on the next trading day is expected to be 0.82 with a mean absolute deviation of 0.03 and the sum of the absolute errors of 1.94. Biofrontera Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Biofrontera's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 10th of January 2026 the rsi of Biofrontera's share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Biofrontera's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Biofrontera, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Biofrontera's stock price prediction:
EPS Estimate Next Quarter
0.11
EPS Estimate Current Year
(1.51)
EPS Estimate Next Year
(0.23)
Wall Street Target Price
6
EPS Estimate Current Quarter
(0.56)
Using Biofrontera hype-based prediction, you can estimate the value of Biofrontera from the perspective of Biofrontera response to recently generated media hype and the effects of current headlines on its competitors.

Biofrontera Hype to Price Pattern

Investor biases related to Biofrontera's public news can be used to forecast risks associated with an investment in Biofrontera. The trend in average sentiment can be used to explain how an investor holding Biofrontera can time the market purely based on public headlines and social activities around Biofrontera. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Biofrontera's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Biofrontera.
The Simple Exponential Smoothing forecasted value of Biofrontera on the next trading day is expected to be 0.82 with a mean absolute deviation of 0.03 and the sum of the absolute errors of 1.94.

Biofrontera after-hype prediction price

    
  USD 0.81  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Biofrontera to cross-verify your projections.
For more detail on how to invest in Biofrontera Stock please use our How to Invest in Biofrontera guide.As of now, Biofrontera's Fixed Asset Turnover is decreasing as compared to previous years. The Biofrontera's current Asset Turnover is estimated to increase to 1.60, while Inventory Turnover is projected to decrease to 1.58. . The Biofrontera's current Common Stock Shares Outstanding is estimated to increase to about 6.7 M, while Net Loss is projected to decrease to (772.8 K).

Biofrontera Additional Predictive Modules

Most predictive techniques to examine Biofrontera price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Biofrontera using various technical indicators. When you analyze Biofrontera charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Biofrontera simple exponential smoothing forecast is a very popular model used to produce a smoothed price series. Whereas in simple Moving Average models the past observations for Biofrontera are weighted equally, Exponential Smoothing assigns exponentially decreasing weights as Biofrontera prices get older.

Biofrontera Simple Exponential Smoothing Price Forecast For the 11th of January 2026

Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Biofrontera on the next trading day is expected to be 0.82 with a mean absolute deviation of 0.03, mean absolute percentage error of 0, and the sum of the absolute errors of 1.94.
Please note that although there have been many attempts to predict Biofrontera Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Biofrontera's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Biofrontera Stock Forecast Pattern

Backtest BiofronteraBiofrontera Price PredictionBuy or Sell Advice 

Biofrontera Forecasted Value

In the context of forecasting Biofrontera's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Biofrontera's downside and upside margins for the forecasting period are 0.01 and 6.90, respectively. We have considered Biofrontera's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.82
0.82
Expected Value
6.90
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Biofrontera stock data series using in forecasting. Note that when a statistical model is used to represent Biofrontera stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria112.0177
BiasArithmetic mean of the errors 0.0023
MADMean absolute deviation0.0318
MAPEMean absolute percentage error0.0374
SAESum of the absolute errors1.94
This simple exponential smoothing model begins by setting Biofrontera forecast for the second period equal to the observation of the first period. In other words, recent Biofrontera observations are given relatively more weight in forecasting than the older observations.

Predictive Modules for Biofrontera

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Biofrontera. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.040.816.89
Details
Intrinsic
Valuation
LowRealHigh
0.102.098.17
Details
2 Analysts
Consensus
LowTargetHigh
5.466.006.66
Details

Other Forecasting Options for Biofrontera

For every potential investor in Biofrontera, whether a beginner or expert, Biofrontera's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Biofrontera Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Biofrontera. Basic forecasting techniques help filter out the noise by identifying Biofrontera's price trends.

Biofrontera Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biofrontera stock to make a market-neutral strategy. Peer analysis of Biofrontera could also be used in its relative valuation, which is a method of valuing Biofrontera by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Biofrontera Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Biofrontera's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Biofrontera's current price.

Biofrontera Market Strength Events

Market strength indicators help investors to evaluate how Biofrontera stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biofrontera shares will generate the highest return on investment. By undertsting and applying Biofrontera stock market strength indicators, traders can identify Biofrontera entry and exit signals to maximize returns.

Biofrontera Risk Indicators

The analysis of Biofrontera's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Biofrontera's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting biofrontera stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

When determining whether Biofrontera offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biofrontera's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biofrontera Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biofrontera Stock:
Check out Historical Fundamental Analysis of Biofrontera to cross-verify your projections.
For more detail on how to invest in Biofrontera Stock please use our How to Invest in Biofrontera guide.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biofrontera. If investors know Biofrontera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biofrontera listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.50)
Revenue Per Share
4.063
Quarterly Revenue Growth
(0.23)
Return On Assets
(0.65)
Return On Equity
(11.92)
The market value of Biofrontera is measured differently than its book value, which is the value of Biofrontera that is recorded on the company's balance sheet. Investors also form their own opinion of Biofrontera's value that differs from its market value or its book value, called intrinsic value, which is Biofrontera's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biofrontera's market value can be influenced by many factors that don't directly affect Biofrontera's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biofrontera's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biofrontera is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biofrontera's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.